Long COVID

Condition: Long COVID (Post-Acute Sequelae of SARS-CoV-2)  |  Category: Post-Viral Recovery / Immune Health  |  Reviewed by: Brian Lamkin, DO

What Is Long COVID?

Long COVID, formally known as post-acute sequelae of SARS-CoV-2 infection (PASC), is a condition in which symptoms persist for four or more weeks following the initial SARS-CoV-2 infection, often with no identifiable end point. Conservative estimates suggest that 10 to 30 percent of COVID-19 survivors develop long COVID, with some cohorts reporting significantly higher rates, making it one of the most widespread post-viral syndromes ever documented.

Long COVID is not a single disease but a heterogeneous clinical syndrome reflecting multiple partially overlapping pathophysiological mechanisms. Current research implicates viral persistence or remnant viral antigen, immune dysregulation and chronic low-grade inflammation, autoimmune activation including autoantibodies targeting G protein-coupled receptors, microbiome disruption, mitochondrial dysfunction, coagulation abnormalities with microthrombus formation, reactivation of latent herpesviruses particularly Epstein-Barr virus, and HPA axis dysregulation as independently contributing mechanisms.

The functional medicine framework is uniquely suited to long COVID because its emphasis on identifying individual drivers and addressing underlying physiological disruptions, rather than managing symptom categories in isolation, aligns precisely with what current understanding of this condition demands.

Why It Matters

Common Symptoms

Root Causes: A Functional Medicine Perspective

Long COVID is mechanistically heterogeneous. Understanding which of the primary drivers is dominant in an individual patient guides a far more effective and efficient treatment approach than symptom management alone.

Immune Dysregulation and Viral Persistence

Long COVID patients show evidence of ongoing immune activation months to years after acute infection, including elevated inflammatory cytokines, activated T cells, and exhausted natural killer cells, even in the absence of detectable viral persistence by standard PCR testing. SARS-CoV-2 RNA and protein have been detected in gut tissue, lymph nodes, and other reservoirs months after acute infection in a subset of patients, potentially driving ongoing immune activation.

Mitochondrial Dysfunction and Microbiome Disruption

Evidence of reduced mitochondrial capacity and oxidative phosphorylation efficiency is documented in long COVID muscle and peripheral blood cells, providing the cellular basis for post-exertional malaise that is biologically grounded rather than psychogenic. The gut microbiome disruption produced by SARS-CoV-2 infection is extensive, persistent, and correlates with ongoing systemic symptom severity across multiple cohort studies.

Autoimmune Activation and Herpesvirus Reactivation

Multiple autoantibody types, including those targeting adrenergic and muscarinic receptors, are found at elevated frequency in long COVID cohorts and may explain autonomic dysfunction, fatigue, and cognitive symptoms. EBV reactivation is documented at higher rates in long COVID patients, adding an additional immune burden through herpesvirus reactivation under the immune exhaustion produced by the acute infection.

Conventional vs Functional Medicine Approach

Key Labs to Evaluate

A complete long COVID evaluation requires testing that goes well beyond standard labs to identify the specific mechanisms driving an individual patient's presentation.

How to Interpret These Labs Together

Common Patterns Seen in Patients

• Normal standard labs with severe functional impairment: the most common presentation; CBC, CMP, and TSH are normal; when we run organic acids, four-point cortisol, stool analysis, and inflammatory markers we find multiple concurrent drivers that provide a clear actionable roadmap
• The patient with prominent POTS-like features: tachycardia on standing, heat intolerance, and fatigue where autonomic dysfunction driven by autoantibodies and microbiome disruption is the primary mechanism; responds to salt and fluid loading, compression garments, and vagal toning before any medication is required
• The previously athletic individual with post-exertional malaise: develops debilitating worsening after any physical activity exceeding a minimal threshold; graded exercise therapy has consistently worsened the condition; pacing and mitochondrial support are foundational
• The cognitive long COVID patient: predominantly cognitive symptoms with poor short-term memory, word-finding difficulty, and reduced processing speed where neuroinflammation and EBV reactivation are likely contributors; responds to low-dose naltrexone and targeted anti-inflammatory support

Treatment and Optimization Strategy

Pacing and Energy Envelope Management as the Foundational First Step

Pacing means staying within an available energy envelope and avoiding the boom-bust cycle of overexertion followed by crash that is the primary driver of long COVID progression. Heart rate monitoring (staying below 60 to 70 percent of maximum) and cognitive load limits are practical pacing tools. The evidence is clear that graded exercise therapy applied without pacing worsens outcomes in long COVID patients with post-exertional malaise.

What Most Doctors Miss

• Post-exertional malaise is not recognized and graded exercise therapy is prescribed: the instinct to encourage deconditioning patients to increase activity is actively harmful in this population; pushing through PEM consistently worsens outcomes and can push a recovering patient into a deeper and more chronic illness state
• The microbiome as a systemic recovery platform is not addressed: robust research demonstrates that SARS-CoV-2 produces profound and lasting gut dysbiosis that correlates with symptom severity and duration; restoring microbial diversity and short-chain fatty acid production is mechanistically central to immune normalization
• The HPA axis component of long COVID fatigue is not measured: blunted cortisol awakening response and low DHEA-S are documented in long COVID cohorts; without a diurnal cortisol assessment this axis remains invisible and fatigue is attributed entirely to deconditioning or psychological factors
• EBV and herpesvirus reactivation are not evaluated: most clinicians check EBV IgG (past exposure) rather than early antigen and IgM markers that indicate active reactivation; the post-viral immune exhaustion window is precisely when latent herpesviruses reactivate and add a second layer of immune burden

When to Seek Medical Care

Persistent symptoms beyond four weeks following SARS-CoV-2 infection that are impairing daily function warrant systematic evaluation rather than watchful waiting. This is particularly true when fatigue, cognitive impairment, or post-exertional malaise are prominent, as these require mechanistic identification and pacing guidance to prevent worsening.

Seek urgent evaluation for chest pain with exertion, significant cardiac arrhythmia, syncope, neurological deficits, or severe dyspnea at rest, as these warrant emergency assessment to rule out acute cardiac or thromboembolic complications before functional management is initiated.

Recommended Testing

Frequently Asked Questions

How The Lamkin Clinic Approaches Long COVID

At The Lamkin Clinic, long COVID evaluation follows a systematic mechanistic framework. We assess for immune activation, mitochondrial dysfunction, gut microbiome disruption, HPA axis dysregulation, coagulation abnormalities, latent viral reactivation, and hormonal disruption as a unified clinical picture. We provide pacing guidance and energy management education as foundational components before any other intervention is introduced.

Related Conditions

Related Symptoms